Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives

HH Schalkwijk, R Snoeck, G Andrei - Biochemical Pharmacology, 2022 - Elsevier
Herpes simplex viruses (HSV), the causative agents of recurrent orofacial and anogenital
infections, can cause significant morbidity and mortality in both immunocompetent and …

Diagnosis and treatment of Kaposi sarcoma

JW Schneider, DP Dittmer - American journal of clinical dermatology, 2017 - Springer
Kaposi sarcoma (KS) is the most common neoplasm of people living with HIV today. In Sub-
Saharan Africa, KS is among the most common cancers in men, overall. Not only HIV …

EBV and human microRNAs co‐target oncogenic and apoptotic viral and human genes during latency

KJ Riley, GS Rabinowitz, TA Yario, JM Luna… - The EMBO …, 2012 - embopress.org
Epstein–Barr virus (EBV) controls gene expression to transform human B cells and maintain
viral latency. High‐throughput sequencing and crosslinking immunoprecipitation (HITS …

Novel therapeutics for Epstein–Barr virus

G Andrei, E Trompet, R Snoeck - Molecules, 2019 - mdpi.com
Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult
population. Primary EBV infection usually occurs during childhood and is generally …

Gammaherpesviruses and lymphoproliferative disorders

E Cesarman - Annual Review of Pathology: Mechanisms of …, 2014 - annualreviews.org
Epstein–Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV), formally designated
human herpesvirus 4 (HHV-4) and 8 (HHV-8), respectively, are viruses that can cause a …

The role of gammaherpesviruses in cancer pathogenesis

HC Jha, S Banerjee, ES Robertson - Pathogens, 2016 - mdpi.com
Worldwide, one fifth of cancers in the population are associated with viral infections. Among
them, gammaherpesvirus, specifically HHV4 (EBV) and HHV8 (KSHV), are two oncogenic …

KSHV: pathways to tumorigenesis and persistent infection

L Giffin, B Damania - Advances in virus research, 2014 - Elsevier
Kaposi's sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8) is
the etiologic agent of Kaposi's sarcoma, primary effusion lymphoma, and multicentric …

Current status of treatment for primary effusion lymphoma

S Okada, H Goto, M Yotsumoto - Intractable & rare diseases …, 2014 - jstage.jst.go.jp
Primary effusion lymphoma (PEL) is a rare and aggressive B-cell non-Hodgkin's lymphoma
that usually presents with malignant effusions without tumor masses. An extracavitary or …

Specific inhibition of viral MicroRNAs by carbon dots-mediated delivery of locked nucleic acids for therapy of virus-induced cancer

E Ju, T Li, Z Liu, SR da Silva, S Wei, X Zhang, X Wang… - ACS …, 2020 - ACS Publications
Viruses are associated with up to 15% of human cancer. MicroRNAs (miRNAs) encoded by
numerous oncogenic viruses including Kaposi's sarcoma-associated herpesvirus (KSHV) …

Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point

E Linke-Serinsöz, F Fend… - Seminars in diagnostic …, 2017 - Elsevier
Abstract The contribution of Epstein Barr virus (EBV) and Kaposi sarcoma herpes virus
(KSHV) to the development of specific types of malignant lymphomas occurring in the …